Journal of Pharmacogenomics & Pharmacoproteomics

Journal of Pharmacogenomics & Pharmacoproteomics
Open Access

ISSN: 2153-0645

+32-466-902163

Upcoming Special Issue

Purpose: To publish the most exciting research with respect to the subjects of Journal of Pharmacogenomics and Pharmacoproteomics and to provide a rapid turn-around time regarding reviewing and publishing, and to disseminate the articles freely for research, teaching and reference purposes.

Special Issue Topics

Special issue entitled: Personalised Medicine is being edited by

  • Leslie Cole Manace
    Department of Genetics
    Kaiser Permanente Oakland Medical Center
    USA
    Tel. 510-752-2029
    Fax 510-752-6754
    E-mail: [email protected]
    logo
  • Martina Kaufmann
    Managing Director
    Germany
    Tel. +49 7631 748652

Special issue entitled: Epigenetics is being edited by

  • Ahmed Esmat Abdel Moneim
    Arab Republic of Egypt
    Zoology & Entomology Department
    Helwan University-Ain Helwan
    11795 Cairo
    Egypt
    logo

Special issue entitled: Pharmacogenitics - HIV is being edited by

Special issue entitled: Toxicogenomics is being edited by

Special issue entitled: OMICS Techniques in Pharmaceutical Sciences is being edited by

Special issue entitled: Structural Biology-Human Diseases is being edited by

Special issue entitled: Thesis is being edited by

Submission Process

Submit Special Issue articles online through manuscript submission, review and editorial tracking system for quality and quick review processing at https://www.longdom.org/pharmacogenomics-pharmacoproteomics/submit-manuscript.html or send as an e-mail attachment to the editorial office at [email protected]

Note:
  1. In case of online submission, please select "Special Issue Article" from the dropdown list.
  2. In case of e-mail, please specify the title of the special issue in the subject and in the cover letter of the submission.

For further information, Please contact us at: Longdom Publishing SL Journals
: +34 911 877 608
: [email protected]

Top